UBS Starts GoodRx Holdings Inc. (GDRX) at Buy
Tweet
Share
E-mailGet Alerts GDRX Hot Sheet
Price: $6.96 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 5
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 5
Join SI Premium – FREE
UBS analyst Eric Sheridan initiates coverage on GoodRx Holdings Inc. (NASDAQ: GDRX) with a Buy rating and a price target of $64.00.
For an analyst ratings summary and ratings history on GoodRx Holdings Inc. click here. For more ratings news on GoodRx Holdings Inc. click here.
Shares of GoodRx Holdings Inc. closed at $53.02 yesterday.
You May Also Be Interested In
- GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
- H.C. Wainwright Starts Processa Pharmaceuticals (PCSA) at Buy
- GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
